Global
Autacoids and Related Drugs Market is expected to grow at a significant CAGR in
the upcoming years as the scope and its applications are increasing across the
globe. Auto means self and Akos means remedy. A group of compounds such as
histamine, prostaglandins, and serotonin that are heterogeneous substances,
which have broadly divergent structures and pharmacologic activities, are
referred to autacoids.
Autacoids
vary from other circulating hormones as many tissues produce them whereas
hormones are produced by specific cells. The factors that propel the growth of
the Autacoids and Related Drugs Market include increasing demand, growing
research and development undertakings, technological innovations and wide range
of applications.
Autacoids
and Related Drugs Market is classified on the basis of product type,
applications, distribution channel and geography. Autacoids and Related Drugs
Industry is segmented by product type as eicosanoids, decarboxylated amino
acids, polypeptides, and others. Autacoids and Related Drugs Market is
classified on applications as allergies, chronic pain, cardiovascular diseases,
gastrointestinal diseases, gastric acid secretion, inflammation, neuroendocrine
regulation, and others.
Autacoids
and Related Drugs Industry is segmented by distribution channel as online
stores, specialty stores and others. Autacoids and Related Drugs Market is
classified on the basis of geography as North America, Latin America, Western
Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The
North American region consists of the U.S., and Canada. Latin America region
consists of Mexico and Brazil. The Western European region consists of Germany,
Italy, France, England and Spain. The Eastern European region consists of
Poland and Russia. Asia Pacific region consists of China, India, ASEAN,
Australia & New Zealand. The Middle East and African region consists of
GCC, South Africa and North Africa.
Some
of the key players that fuel the growth of the Autacoids and Related Drugs
Market include AstraZeneca, APP Pharma, Abbott Laboratories, Bristol-Myers
Squibb, Bedford Laboratories, Chattem, Hospira, Sanofi, Xanodyne, and others.
The key players are focusing on inorganic growth to sustain themselves amidst
fierce competition. As such, mergers, acquisitions, and joint ventures are the
need of the hour.
Comments
Post a Comment